4Vitali C, Bombardieri S, Moutsopoulos, et al. Preliminary criteria for the classification of Sjogren' s syndrome. Results of a prospective concerted action supported by the European Community. Arthritis Rheumatol, 1993, 36: 340-347. 被引量：1
6Vitali C, Bombardieri S, Jonsson R, et al. Classification criteria for Sjogren's syndrome: a revised version of the European criteria proposed by the American-European Consensus Group. Ann Rheum Dis, 2002, 61: 554-558. 被引量：1
7Vitali C, Palombi G, Baldini C, et al. Sjogren's syndrome disease damage index and disease activity index. Scoring systems for the assessment of disease damage and disease activity in Sjogren's syndrome, derived from an analysis of a cohort of Italian patients. Arthritis Rheum, 2007, 56:2223-2231. 被引量：1
8Mont MA, Glueck C J, Pacheco IH, et al. Risk factors for osteonecrosis in systemic lupus erythematosus. J Rheumatol, 1997, 24 : 654-662. 被引量：1
9Gladman DD, Urowitz MB, Chaudhry-Ahluwalia V, et al. Predictive factors for symptomatic osteonecrosis in patients with systemic lupus erythematosus. J Rheumatol,2001,28 :761-765. 被引量：1
10Asherson RA, Liote F, Page B, et al. Avascular necrosis of bone and antiphospholipid antibodies in systemic lupus erythematosus. J Rheumatol, 1993,20:284-288. 被引量：1
2White D, Fayez S, Doube A. Atherogenic lipid profiles in rheumatoid arthritis[J]. N Z Med J, 2006,119(1240) : U2125. 被引量：1
3de Groot L,Posthumus MD,Kallenberg CG,et al. Risk factors and early deteetion of atheroselerosis in rheumatoid arthritis [J]. Eur J Clin Invest,2010,40(9) :835-842. 被引量：1
4Mudau M,Genis A,Lochner A, et al. Endothelial dysfunction: the early predictor of atherosclerosis[J]. Cardiovasc J Afr, 2012,23(4) : 222-231. 被引量：1
5Galkina E, Ley K. Vascular adhesion molecules in atherosclerosis[J]. Arterioscler Thromb Vasc Biol, 2007, 27 (11) :2292-2301. 被引量：1
